Uptravi

Uptravi Contraindications

selexipag

Manufacturer:

Janssen-Cilag

Distributor:

DKSH
Full Prescribing Info
Contraindications
Hypersensitivity to the active substance or to any of the excipients (see Description).
Severe coronary heart disease or unstable angina.
Myocardial infarction within the last 6 months.
Decompensated cardiac failure if not under close medical supervision.
Severe arrhythmias.
Cerebrovascular events (e.g., transient ischaemic attack, stroke) within the last 3 months.
Congenital or acquired valvular defects with clinically relevant myocardial function disorders not related to pulmonary hypertension.
Concomitant use of strong inhibitors of CYP2C8 (e.g., gemfibrozil; see Interactions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in